Endocrine Oncology key journal metrics

Average time to first response: 43 days
Acceptance rate: 29%
 

 

EDITOR-IN-CHIEF

Professor Justo Castaño
 
Justo P Castaño, PhD
Professor of Cell Biology,
Head, Hormones and Cancer Research Group,
Maimonides Biomedical Research Institute of Cordoba,
Reina Sofía University Hospital and University of Cordoba,
Spain
 
Browse the full Editorial Board

January 26, 2021

Article Publication Charge Waived

 

In celebration of the launch of Endocrine Oncology, Bioscientifica is sponsoring the Article Publication Charge during the launch years of the journal.

 

 

January 26, 2021

Endocrine Oncology – now open for submissions

 

Bioscientifica is pleased to announce the launch of their new fully open-access, peer-reviewed journal, Endocrine Oncology, endorsed by the Society for Endocrinology.

Led by Editor-in-Chief Edward P Gelmann, Endocrine Oncology will see vigorous yet rapid peer review of the latest basic, translational and clinical research in the field.

 

 

Endocine Oncology alerts sign up advert

 

 

Endocine Oncology publish free advert

 

 

Endocine Oncology find out about the editorial board advert